Previous close | 27.80 |
Open | 27.80 |
Bid | 25.60 |
Ask | 29.90 |
Strike | 65.00 |
Expiry date | 2025-01-17 |
Day's range | 27.80 - 27.80 |
Contract range | N/A |
Volume | |
Open interest | 14 |
Glaukos announces positive second Phase 3 confirmatory pivotal trial for Epioxa.
ARAY's solid product demand and revenue growth raise optimism about the stock.
DEERFIELD, Ill., October 16, 2024--Baxter International Inc. (NYSE:BAX), a global medtech leader, will host a conference call to discuss its third-quarter 2024 financial results on Friday, November 8, 2024 at 7:30 a.m. Central Time. To participate in this conference call please follow this link https://events.q4inc.com/attendee/391655054 to pre-register for the call and receive the call information.